ESCMID's open-access journal with companion podcast (Communicable) for all things infectious diseases, clinical microbiology, AMR & stewardship #IDSky #MedSky #EpiSky #ClinMicro
ποΈ https://www.cmi-comms.org/

@cmicomms.bsky.social
ESCMID's open-access journal with companion podcast (Communicable) for all things infectious diseases, clinical microbiology, AMR & stewardship #IDSky #MedSky #EpiSky #ClinMicro
ποΈ https://www.cmi-comms.org/
Happy to confirm: attendees receive 16 European CME credits
Malta, 19-21 Nov π
Great faculty (@gurujosh.bsky.social @steventong.bsky.social David Paterson, others)
Register www.escmid.org/event-detail...
Organized by @clarityinitiative.bsky.social @cmicomms.bsky.social @escmid.bsky.social
#IDSky
ποΈ Just published Communicable E64: Getting micro on macrolides for community-acquired pneumonia
Hosted by Marc Bonten & Emily McDonald with invited guests Valentijn Schweitzer & Sylvain Lother π
Listen on #Communicable: https://share.transistor.fm/s/deec5589
π£ New #Communicable drops Mon 05 Oct!
Marc Bonten & Emily McDonald are joined by Valentijn Schweitzer & Sylvain Lother to discuss the use of macrolides in community-acquired pneumonia and how the available evidence informs clinical practice. Tune in!
π£ More evidence that less is probably more:
During a global shortage of #bloodculture bottles, Japanese hospitals reduced the number of sets drawn per patient.
Contamination rates went down, while detection rates of real pathogens did not.
The next Clarity commentary. On the SNAP trial. Neither I nor @gurujosh.bsky.social had anything to do with this commentary (deliberately).
Conclusions though are in line with my interpretation of the data. i.e., use cefazolin for MSSA bacteremia.
@angelahuttner.bsky.social @cmicomms.bsky.social
Yes, it is only a preprint at the moment. Not yet published definitively (peer review/revision ongoing).
Really appreciate the depth that Communicable provides to these studies. Itβs context, nuance, applicability, everything π₯°
So excited for this episode, as we head into the northern hemisphere flu season... the first few cases now coming into our hospital... what do we do... π€ π€·
#IDsky
#clinmicro
ποΈ Just published 'Does oseltamivir harm critically ill patients? The REMAP-CAP results'
Hosted by Erin McCreary, PharmD & Josh Davis with invited guests Steve Webb & Steven Tong π
Listen on #Communicable https://ow.ly/pJAO50ZOfK8 or on #Breakpoints https://ow.ly/p8Ti50ZOfK9
π£ New #Communicable / #Breakpoints drops Mon 21 Sep!
Erin McCreary, PharmD & Josh Davis are joined by Steve Webb & Steven Tong to discuss REMAP-CAP results suggesting that oseltamivir may harm critically ill patients, while also highlighting the importance and impact of RCTs.
π‘ Take your clinical trial from concept to completion. Learn how to design, conduct and report a clinical trial through expert-led sessions and workshops covering every stage of the clinical trial journey.
Register today: https://ow.ly/lStL50Zrgqa
#IDSky CMI Communications CLARITY_Initiative
ποΈ Just published Communicable E62: the 'prose' and cons of the POET trial β early oral antibiotic switch for endocarditis
Hosted by Emily McDonald & Josh Davis with invited guests Henning Bundgaard and Sami El-Dalati π
Listen on #Communicable: https://share.transistor.fm/s/d5eb49ac
π£ New #Communicable drops Mon 03 Sep!
Emily McDonald & Josh Davis are joined by Henning Bundgaard & Sami El-Dalati to revisit the POET trial and discuss the βproseβ and cons of early oral switch for #endocarditis as well as challenges of implementing new evidence against long-standing dogma.
π£We rely more & more on #AI for literature review
So how did 6 large language models compare to humans when extracting data from #RCTs for a systematic review?
Not very well: overall #LLM concordance was 0.58-0.75.
#IDSky
@steventong.bsky.social
@seanong.bsky.social
cmi-comms.org/article/S295...
π£ New #Communicable drops Mon 10 Aug!
Emily McDonald and Erin McCreary, PharmD host Quarterly catch-up to review new studies: when post-transplant is PCP likely to occur? How did procalcitonin do in the BALANCE trial? How did cefepimeβnacubactam do vs imipenem in cUTI patients?ποΈ
ποΈ Just published: Communicable E42...
Hosted by @angelahuttner.bsky.social & @marcbonten.bsky.social
w/ invited guests Ilan Schwartz @germhuntermd.bsky.social, Neil Stone @drneilstone.bsky.social & Tara Smith @aetiology.bsky.social
Listen on #Communicable:
#IDSky #Clinmicro #IDTwitter